Thyrosafe (Potassium Iodide) Dosing for Radiation Exposure
Adults over 18 years should take 130 mg (2 mL) daily, while children receive weight- and age-based doses ranging from 16.25 mg for newborns to 130 mg for adolescents weighing ≥150 pounds, administered as a single daily dose only when directed by public officials during a confirmed radioactive iodine emergency. 1
Age-Based Dosing Algorithm
Adults and Adolescents
- Adults over 18 years: 130 mg (2 mL) once daily 1
- Adolescents 12-18 years weighing ≥150 pounds: 130 mg (2 mL) once daily 1
- Adolescents 12-18 years weighing <150 pounds: 65 mg (1 mL) once daily 1
Pediatric Populations
- Children 3-12 years: 65 mg (1 mL) once daily 1
- Children 1 month to 3 years: 32.5 mg (0.5 mL) once daily 1
- Newborns (birth to 1 month): 16.25 mg (0.25 mL) once daily 1
Critical Timing Considerations
Administer potassium iodide as soon as possible after public officials direct you to do so, ideally within 4 hours of radioactive iodine exposure to achieve approximately 50% reduction in thyroid uptake. 2, 3
- Maximum protective effect occurs when administered within 6 hours of exposure 3, 4
- Efficacy decreases significantly if delayed beyond this window 4
- When administered just before exposure, KI blocks at least 95% of thyroid radiation dose 5
Repeat Dosing Protocol
- Take only ONE dose per 24-hour period 1
- If repeat dosing is necessary, wait exactly 24 hours after the first dose 1
- Continue daily dosing only as long as public officials direct, until risk of major radioactive iodine exposure ceases 1
- In cases of continued or repeated radioiodine release, daily dosing up to 1 week may be necessary and is not harmful 6
- Daily doses of 15 mg can maintain thyroid blockade above 90% during persistent exposure 5
High-Risk Population Considerations
Children and Adolescents
- This age group requires the most stringent protection measures due to markedly higher sensitivity to radiation-induced thyroid cancer 2, 7
- The risk of radiation-induced thyroid cancer justifies KI prophylaxis despite potential hypothyroidism risk, especially in newborns 5
- Newborns and babies may be more sensitive to side effects and require monitoring 6
Pregnant Women
- Pregnant women should receive the same adult dose (130 mg) as the most important factor for fetal survival is maternal survival 2
- Use cautiously, especially after the first trimester, as KI can affect the fetal thyroid 3
- The fetal thyroid is more iodine-avid than the adult thyroid, resulting in higher radiation doses during maternal exposure 2
- Any pregnant woman exposed to more than 0.25 Gy of radiation requires fetal dose estimation by a health physicist 2
Critical Safety Warnings
When NOT to Use Potassium Iodide
Potassium iodide is NOT a generic antiradiation drug and should only be used for confirmed radioiodine exposure. 2
- In "dirty bomb" scenarios, radioiodines are extremely unlikely to be present due to their short 8.5-day half-life 2
- KI administration in these inappropriate cases risks life-threatening anaphylaxis without benefit 2
- Individuals with iodine allergy history may experience severe allergic reactions including anaphylaxis 2, 3
Monitoring Requirements
- Monitor patients for side effects, particularly thyroid dysfunction and allergic manifestations 3
- Stop KI immediately if severe side effects occur 3
- Do not exceed one dose per 24 hours, as more will not provide additional protection and increases side effect risk 1
Common Pitfalls to Avoid
- Never take more than one dose in 24 hours - the thyroid can only "hold" certain amounts of iodine, and excess increases side effects without benefit 1
- Do not use for general radiation exposure - only effective for radioactive iodine, not other radiation types 2
- Do not delay administration - effectiveness drops dramatically after 6 hours post-exposure 3, 4
- In iodine-deficient populations, radioiodine uptake risk is higher, making timely KI administration even more critical 6, 8